Preferences for herpes zoster vaccination among adults aged 50 years and older in the United States: results from a discrete choice experiment.

Published in: Expert review of vaccines (2021)

For all respondents, HZ vaccine choices were most sensitive to total OOP cost, followed by VE.

Keyphrases